Literature DB >> 27267121

Primary cancer cell culture: mammary-optimized vs conditional reprogramming.

Ahmad M Alamri1, Keunsoo Kang2, Svenja Groeneveld3, Weisheng Wang4, Xiaogang Zhong5, Bhaskar Kallakury6, Lothar Hennighausen7, Xuefeng Liu6, Priscilla A Furth8.   

Abstract

The impact of different culture conditions on biology of primary cancer cells is not always addressed. Here, conditional reprogramming (CRC) was compared with mammary-optimized EpiCult-B (EpiC) for primary mammary epithelial cell isolation and propagation, allograft generation, and genome-wide transcriptional consequences using cancer and non-cancer mammary tissue from mice with different dosages of Brca1 and p53 Selective comparison to DMEM was included. Primary cultures were established with all three media, but CRC was most efficient for initial isolation (P<0.05). Allograft development was faster using cells grown in EpiC compared with CRC (P<0.05). Transcriptome comparison of paired CRC and EpiC cultures revealed 1700 differentially expressed genes by passage 20. CRC promoted Trp53 gene family upregulation and increased expression of epithelial differentiation genes, whereas EpiC elevated expression of epithelial-mesenchymal transition genes. Differences did not persist in allografts where both methods yielded allografts with relatively similar transcriptomes. Restricting passage (<7) reduced numbers of differentially expressed genes below 50. In conclusion, CRC was most efficient for initial cell isolation but EpiC was quicker for allograft generation. The extensive culture-specific gene expression patterns that emerged with longer passage could be limited by reducing passage number when both culture transcriptomes were equally similar to that of the primary tissue. Defining impact of culture condition and passage on the transcriptome of primary cells could assist experimental design and interpretation. For example, differences that appear with passage and culture condition are potentially exploitable for comparative studies targeting specific biological networks in different transcriptional environments.
© 2016 Society for Endocrinology.

Entities:  

Keywords:  Brca1; genetically engineered mouse models; mammary cancer; primary cell culture; transcriptome

Mesh:

Year:  2016        PMID: 27267121      PMCID: PMC4962879          DOI: 10.1530/ERC-16-0071

Source DB:  PubMed          Journal:  Endocr Relat Cancer        ISSN: 1351-0088            Impact factor:   5.678


  56 in total

1.  Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies.

Authors:  Brian D Lehmann; Joshua A Bauer; Xi Chen; Melinda E Sanders; A Bapsi Chakravarthy; Yu Shyr; Jennifer A Pietenpol
Journal:  J Clin Invest       Date:  2011-07       Impact factor: 14.808

2.  Mammary-specific gene activation is defined by progressive recruitment of STAT5 during pregnancy and the establishment of H3K4me3 marks.

Authors:  Keunsoo Kang; Daisuke Yamaji; Kyung Hyun Yoo; Gertraud W Robinson; Lothar Hennighausen
Journal:  Mol Cell Biol       Date:  2013-11-25       Impact factor: 4.272

3.  The morphological and molecular features of the epithelial-to-mesenchymal transition.

Authors:  Gema Moreno-Bueno; Héctor Peinado; Patricia Molina; David Olmeda; Eva Cubillo; Vanesa Santos; José Palacios; Francisco Portillo; Amparo Cano
Journal:  Nat Protoc       Date:  2009-10-15       Impact factor: 13.491

4.  Development of mammary luminal progenitor cells is controlled by the transcription factor STAT5A.

Authors:  Daisuke Yamaji; Risu Na; Yonatan Feuermann; Susanne Pechhold; Weiping Chen; Gertraud W Robinson; Lothar Hennighausen
Journal:  Genes Dev       Date:  2009-10-15       Impact factor: 11.361

5.  Keratins as markers that distinguish normal and tumor-derived mammary epithelial cells.

Authors:  D K Trask; V Band; D A Zajchowski; P Yaswen; T Suh; R Sager
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

6.  Human keratinocytes are efficiently immortalized by a Rho kinase inhibitor.

Authors:  Sandra Chapman; Xuefeng Liu; Craig Meyers; Richard Schlegel; Alison A McBride
Journal:  J Clin Invest       Date:  2010-07       Impact factor: 14.808

Review 7.  Signaling mechanisms of the epithelial-mesenchymal transition.

Authors:  David M Gonzalez; Damian Medici
Journal:  Sci Signal       Date:  2014-09-23       Impact factor: 8.192

8.  Dynamic actin remodeling during epithelial-mesenchymal transition depends on increased moesin expression.

Authors:  Jennifer Haynes; Jyoti Srivastava; Nikki Madson; Torsten Wittmann; Diane L Barber
Journal:  Mol Biol Cell       Date:  2011-10-26       Impact factor: 4.138

9.  Keratin 6 is not essential for mammary gland development.

Authors:  Sandra L Grimm; Wen Bu; Mary Ann Longley; Dennis R Roop; Yi Li; Jeffrey M Rosen
Journal:  Breast Cancer Res       Date:  2006-06-21       Impact factor: 6.466

10.  Global analysis of p53-regulated transcription identifies its direct targets and unexpected regulatory mechanisms.

Authors:  Mary Ann Allen; Zdenek Andrysik; Veronica L Dengler; Hestia S Mellert; Anna Guarnieri; Justin A Freeman; Kelly D Sullivan; Matthew D Galbraith; Xin Luo; W Lee Kraus; Robin D Dowell; Joaquin M Espinosa
Journal:  Elife       Date:  2014-05-27       Impact factor: 8.140

View more
  10 in total

1.  Conditionally reprogrammed macaque endocervical cells retain steroid receptor expression and produce mucus.

Authors:  Leo Han; Walker Andrews; Karsten Wong; Jeffrey T Jensen
Journal:  Biol Reprod       Date:  2020-05-26       Impact factor: 4.285

Review 2.  Peroxisome proliferator-activated receptor gamma and BRCA1.

Authors:  Priscilla A Furth
Journal:  Endocr Relat Cancer       Date:  2019-02       Impact factor: 5.678

3.  Responsiveness of Brca1 and Trp53 Deficiency-Induced Mammary Preneoplasia to Selective Estrogen Modulators versus an Aromatase Inhibitor in Mus musculus.

Authors:  Sahar J Alothman; Weisheng Wang; David S Goerlitz; Md Islam; Xiaogang Zhong; Archana Kishore; Redha I Azhar; Bhaskar V Kallakury; Priscilla A Furth
Journal:  Cancer Prev Res (Phila)       Date:  2017-03-10

Review 4.  Conditionally Reprogrammed Human Normal Airway Epithelial Cells at ALI: A Physiological Model for Emerging Viruses.

Authors:  Xuefeng Liu; Yuntao Wu; Lijun Rong
Journal:  Virol Sin       Date:  2020-06-17       Impact factor: 4.327

Review 5.  Conditional cell reprogramming for modeling host-virus interactions and human viral diseases.

Authors:  Xuefeng Liu; Abdul M Mondal
Journal:  J Med Virol       Date:  2020-06-16       Impact factor: 2.327

6.  Characterization of transcriptome diversity and in vitro behavior of primary human high-risk breast cells.

Authors:  Sahar J Alothman; Keunsoo Kang; Xuefeng Liu; Ewa Krawczyk; Redha I Azhar; Rong Hu; David Goerlitz; Bhaskar V Kallakury; Priscilla A Furth
Journal:  Sci Rep       Date:  2022-04-22       Impact factor: 4.996

Review 7.  Conditional Cell Reprogramming in Modeling Digestive System Diseases.

Authors:  Ruihua Zhao; Rui Li; Tianqi An; Xuefeng Liu
Journal:  Front Cell Dev Biol       Date:  2021-06-03

8.  Expanding primary cells from mucoepidermoid and other salivary gland neoplasms for genetic and chemosensitivity testing.

Authors:  Ahmad M Alamri; Xuefeng Liu; Jan K Blancato; Bassem R Haddad; Weisheng Wang; Xiaogang Zhong; Sujata Choudhary; Ewa Krawczyk; Bhaskar V Kallakury; Bruce J Davidson; Priscilla A Furth
Journal:  Dis Model Mech       Date:  2018-01-29       Impact factor: 5.758

9.  Proliferation of human hepatocellular carcinoma cells from surgically resected specimens under conditionally reprogrammed culture.

Authors:  Zhenglu Wang; Bowen Bi; Hongli Song; Lei Liu; Hong Zheng; Shusen Wang; Zhongyang Shen
Journal:  Mol Med Rep       Date:  2019-04-12       Impact factor: 2.952

Review 10.  Conditional Reprogramming for Patient-Derived Cancer Models and Next-Generation Living Biobanks.

Authors:  Nancy Palechor-Ceron; Ewa Krawczyk; Aleksandra Dakic; Vera Simic; Hang Yuan; Jan Blancato; Weisheng Wang; Fleesie Hubbard; Yun-Ling Zheng; Hancai Dan; Scott Strome; Kevin Cullen; Bruce Davidson; John F Deeken; Sujata Choudhury; Peter H Ahn; Seema Agarwal; Xuexun Zhou; Richard Schlegel; Priscilla A Furth; Chong-Xian Pan; Xuefeng Liu
Journal:  Cells       Date:  2019-10-27       Impact factor: 7.666

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.